The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback